BCE Inc
BCE
The Toronto-Dominion Bank
TD
TELUS Corp
T
Brookfield Renewable Partners LP
BEP.UN
Choice Properties Real Estate Investment Trust
CHP.UN
CA Stock MarketDetailed Quotes
MDMA Pharmala Biotech Holdings Inc
- 0.295
- +0.025+9.26%
15min DelayMarket Closed Jan 3 15:59 ET
27.82MMarket Cap-29.50P/E (TTM)
0.295High0.260Low311.36KVolume0.275Open0.270Pre Close86.52KTurnover0.35052wk High0.33%Turnover Ratio94.29MShares0.06552wk Low-0.01EPS TTM27.82MFloat Cap0.540Historical HighLossP/E (Static)94.29MShs Float0.020Historical Low-0.01EPS LYR12.96%Amplitude--Dividend TTM14.05P/B1Lot Size--Div YieldTTM
About Pharmala Biotech Holdings Inc Company
Pharmala Biotech Holdings Inc is focused on manufacturing and sales of MDMA and MDXX Active Pharmaceutical Ingredients (API) for use in clinical research. Its drug API is manufactured and encapsulated under GMP conditions. The company generates revenue from the sale of tablets and raw MDMA and MDXX compounds/formulations and royalties from licensing of its IP.
Company Profile
SymbolMDMA
Company NamePharmala Biotech Holdings Inc
Founded2020
MarketCNQ
Employees10
Fiscal Year Ends08-31
Address1 Adelaide Street East Suite 801
CityToranto
CountryCAN
Zip CodeM5C 2V9
Phone+1 855 444-6362
Websitehttps://www.pharmala.ca
Company Executives
No Data
Trending CA Stocks
Dividend Kings of Canada Dividend Kings of Canada
Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.